Joseph Drayton

Joseph Drayton is a partner and co-head of the Patent Law practice at Proskauer Rose LLP, specializing in a broad range of intellectual property litigation. His practice encompasses patent, trade secrets, copyright, trademark, trade dress, and false advertising disputes, both domestically and internationally. Drayton advises clients across diverse industries, including medical devices, semiconductor chips, inventory management, and network systems, and also counsels on IP acquisition, transfer, protection, and enforcement strategies. He joined Proskauer Rose in November 2023 from Cooley LLP.

As a first-chair trial lawyer, Mr. Drayton has represented prominent companies in high-stakes IP and complex commercial litigation before state and federal courts, the International Trade Commission (ITC), and arbitration tribunals. He has secured favorable outcomes for clients, including a successful verdict at trial for a spinal fusion medical device manufacturer in Delaware and an ITC finding of non-infringement for a major semiconductor chip manufacturer. He also led Blackhawk Network to a favorable jury verdict in a patent infringement suit and has achieved successful pre-trial dismissals for Bloomberg and leading technology companies in patent and trade secret disputes. His tracked case appearances include Haemonetics Corporation v. Fresenius Kabi USA, LLC et al. (plaintiff) and Terumo BCT Inc. v. Haemonetics Corp. (defendant), where he served as back-up counsel.

Drayton also possesses experience in PTAB proceedings, contributing articles and insights on topics like inter partes review (IPR). He earned his B.S. from the University of Maryland and his J.D. from the University of Pennsylvania Law School in 1997, and was admitted to legal practice in 1998.